Visit https://www.peervoice.com/JMS860 to view the entire programme with slides. After completing “Taking Check of Advanced Non-Melanoma Skin Cancers: Exploring the Clinical Impact of Systemic Immunotherapies”, participants will be able to: Evaluate the latest evidence for systemic immunotherapies in the management of advanced non-melanoma skin cancer and how these may potentially impact practice; Identify patient and disease characteristics that may influence the decision to offer immunotherapy for patients with advanced non-melanoma skin cancer; Formulate individualised treatment plans for patients with non-melanoma skin cancer who require systemic immunotherapy, considering disease- and patient-specific factors.